Tecan Group has acquired Wako Automation assets, including Director™ scheduling software, to enhance its laboratory automation offerings and address the growing demand for integrated solutions in the biopharma sector.

Information on the Target

Tecan Group, headquartered in Männedorf, Switzerland, is a globally recognized leader in laboratory automation. On December 2, 2025, Tecan announced its acquisition of Wako Automation’s assets, which includes the flagship Director™ scheduling software and several select hardware modules. This acquisition was finalized on December 1, 2025, and will enable Tecan to enhance its offerings in laboratory automation.

The Director™ software, known for optimizing complex workflows in laboratories, allows seamless integration with Tecan’s advanced liquid handling platforms. This strategic move marks a pivotal step in Tecan’s efforts to expand its addressable market, moving beyond its traditional focus on liquid handling systems and reinforcing its role in the broader laboratory automation sector.

Industry Overview in Switzerland

Switzerland has a robust and innovative life sciences sector, characterized by a strong emphasis on research and development. The country hosts numerous pharmaceutical and biotechnology companies, which are criti